MEDICLINIC INTERNATIONAL PLC

Major Shareholding Notification • Dec 5, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9772Q

Mediclinic International PLC

05 December 2016

Mediclinic International plc 

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

5 December 2016

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			MEDICLINIC INTERNATIONAL PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:		PUBLIC INVESTMENT CORPORATION SOC LIMITED
4. Full name of shareholder(s)  (if different from 3.):		N/A
5. Date of the transaction and date on which the threshold is crossed or reached:		01 December 2016
6. Date on which issuer notified:		02 December 2016
7. Threshold(s) that is/are crossed or reached:		8%

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction							Resulting situation after the triggering transaction
Number of Shares				Number of Voting Rights			Number of shares		Number of voting rights			% of  voting rights
Direct		Direct		Indirect	Direct			Indirect
MEI ORDINARY SHARES	59 239 493							58 705 799					7.963%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date			Exercise/ Conversion Period					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
NONE			N/A			N/A					N/A				N/A
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date			Exercise/ Conversion period		Number of voting rights instrument refers to					% of voting rights
														Nominal			Delta
Total (A+B+C)
Number of voting rights									Percentage of voting rights
58 705 799									7.963%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
N/A
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	N/A
14. Contact name:	DEVILLIERS MAKONKO
15. Contact telephone number:	012 742 3578

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUVOARNKAURAA